Journal article
Anemia management in chronic kidney disease and dialysis
Abstract
PURPOSE OF REVIEW: This review describes the current state of anemia management with erythropoietin (EPO)-stimulating agents and iron supplementation in both chronic kidney disease and dialysis patients, with a focus on novel therapies.
RECENT FINDINGS: We review the benefits and risks of EPO-stimulating agents, focusing on health-related quality of life and the uncertainties regarding optimal iron utilization in patients with kidney disease. …
Authors
Collister D; Rigatto C; Tangri N
Journal
Current Opinion in Nephrology & Hypertension, Vol. 26, No. 3, pp. 214–218
Publisher
Wolters Kluwer
Publication Date
May 2017
DOI
10.1097/mnh.0000000000000317
ISSN
1062-4821